RadNet, Inc. Operating Cash Flow
RadNet, Inc. (RDNT) reported Operating Cash Flow of $173.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- RadNet, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $94.10M, a 21.81% decline year-over-year.
- RadNet, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $78.97M, a 90.38% increase year-over-year.
- RadNet, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $84.16M, a 97.90% increase year-over-year.
- RadNet, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $52.83M, a 7.97% decline year-over-year.
- RadNet, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $298.82M, a 28.24% increase from fiscal 2024.
- RadNet, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $233.02M, a 5.51% increase from fiscal 2023.
- RadNet, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $220.86M, a 50.85% increase from fiscal 2022.
- RadNet, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $146.42M, a 2.06% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $173.07M 10-Q · filed 2026-08-10 | $257.24M derived: sum of 3 quarters · filed 2026-08-10 | $310.06M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $78.97M 10-Q · filed 2026-05-11 | $163.14M derived: sum of 2 quarters · filed 2026-05-11 | $215.96M derived: sum of 3 quarters · filed 2026-05-11 | $336.31M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $84.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $136.99M derived: sum of 2 quarters · filed 2026-03-02 | $257.34M derived: sum of 3 quarters · filed 2026-08-10 | $298.82M 10-K · filed 2026-03-02 | ||
| 2025-09-30 | $52.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $173.18M derived: sum of 2 quarters · filed 2026-08-10 | $214.66M 10-Q · filed 2025-11-10 | $257.19M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $120.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $161.83M 10-Q · filed 2026-08-10 | $204.36M derived: sum of 3 quarters · filed 2026-08-10 | $261.76M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $41.48M 10-Q · filed 2026-05-11 | $84.01M derived: sum of 2 quarters · filed 2026-05-11 | $141.41M derived: sum of 3 quarters · filed 2026-05-11 | $257.42M derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $42.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $99.93M derived: sum of 2 quarters · filed 2026-03-02 | $215.94M derived: sum of 3 quarters · filed 2026-03-02 | $233.02M 10-K · filed 2026-03-02 | ||
| 2024-09-30 | $57.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $173.41M derived: sum of 2 quarters · filed 2025-11-10 | $190.49M 10-Q · filed 2025-11-10 | $279.41M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-06-30 | $116.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $133.09M 10-Q · filed 2025-08-11 | $222.01M derived: sum of 3 quarters · filed 2026-03-02 | $253.26M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-03-31 | $17.09M 10-Q · filed 2025-05-12 | $17.09M 10-Q · filed 2024-05-10 | $106.01M derived: sum of 2 quarters · filed 2026-03-02 | $137.26M derived: sum of 3 quarters · filed 2026-03-02 | $205.34M derived: sum of 4 quarters · filed 2026-03-02 | |
| 2023-12-31 | $88.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $120.17M derived: sum of 2 quarters · filed 2026-03-02 | $188.25M derived: sum of 3 quarters · filed 2026-03-02 | $220.86M 10-K · filed 2026-03-02 | ||
| 2023-09-30 | $31.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $99.33M derived: sum of 2 quarters · filed 2024-11-12 | $131.94M 10-Q · filed 2024-11-12 | $185.59M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | $68.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $100.69M 10-Q · filed 2024-08-09 | $154.34M derived: sum of 3 quarters · filed 2025-03-03 | $181.36M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $32.62M 10-Q · filed 2024-05-10 | $86.26M derived: sum of 2 quarters · filed 2025-03-03 | $113.29M derived: sum of 3 quarters · filed 2025-03-03 | $178.13M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $53.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $80.67M derived: sum of 2 quarters · filed 2025-03-03 | $145.52M derived: sum of 3 quarters · filed 2025-03-03 | $146.42M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $27.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $91.87M derived: sum of 2 quarters · filed 2023-11-09 | $92.77M 10-Q · filed 2023-11-09 | $141.97M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $64.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $65.74M 10-Q · filed 2023-08-09 | $114.94M derived: sum of 3 quarters · filed 2024-02-29 | $156.53M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $901.00K 10-Q · filed 2023-05-10 | $50.10M derived: sum of 2 quarters · filed 2024-02-29 | $91.69M derived: sum of 3 quarters · filed 2024-02-29 | $122.31M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $49.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $90.79M derived: sum of 2 quarters · filed 2024-02-29 | $121.41M derived: sum of 3 quarters · filed 2024-02-29 | $149.49M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $41.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $72.21M derived: sum of 2 quarters · filed 2022-11-09 | $100.30M 10-Q · filed 2022-11-09 | $163.71M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $30.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $58.70M 10-Q · filed 2022-08-09 | $122.12M derived: sum of 3 quarters · filed 2023-03-01 | $161.00M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $28.08M 10-Q · filed 2022-05-10 | $91.50M derived: sum of 2 quarters · filed 2023-03-01 | $130.38M derived: sum of 3 quarters · filed 2023-03-01 | $220.93M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $63.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $102.29M derived: sum of 2 quarters · filed 2023-03-01 | $192.85M derived: sum of 3 quarters · filed 2023-03-01 | $233.76M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $38.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $129.43M derived: sum of 2 quarters · filed 2021-11-09 | $170.34M 10-Q · filed 2021-11-09 | $192.06M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $90.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $131.47M 10-Q · filed 2021-08-09 | $153.18M derived: sum of 3 quarters · filed 2022-03-01 | $191.25M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $40.91M 10-Q · filed 2021-05-10 | $62.63M derived: sum of 2 quarters · filed 2022-03-01 | $100.70M derived: sum of 3 quarters · filed 2022-03-01 | $118.33M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $21.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $59.79M derived: sum of 2 quarters · filed 2022-03-01 | $77.42M derived: sum of 3 quarters · filed 2022-03-01 | $104.32M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $38.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $55.70M derived: sum of 2 quarters · filed 2020-11-09 | $82.60M 10-Q · filed 2020-11-09 | $111.50M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-06-30 | $17.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $44.53M 10-Q · filed 2020-08-10 | $73.43M derived: sum of 3 quarters · filed 2021-03-16 | $114.34M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-03-31 | $26.90M 10-Q · filed 2020-05-11 | $55.80M derived: sum of 2 quarters · filed 2021-03-16 | $96.71M derived: sum of 3 quarters · filed 2021-03-16 | $119.34M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2018-12-31 | $28.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $69.81M derived: sum of 2 quarters · filed 2021-03-16 | $92.44M derived: sum of 3 quarters · filed 2021-03-16 | $116.75M 10-K · filed 2021-03-16 | ||
| 2018-09-30 | $40.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $63.55M derived: sum of 2 quarters · filed 2019-11-12 | $87.86M 10-Q · filed 2019-11-12 | $154.50M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2018-06-30 | $22.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $46.95M 10-Q · filed 2019-08-09 | $113.59M derived: sum of 3 quarters · filed 2020-03-16 | $139.01M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2018-03-31 | $24.31M 10-Q · filed 2019-05-10 | $90.95M derived: sum of 2 quarters · filed 2020-03-16 | $116.38M derived: sum of 3 quarters · filed 2020-03-16 | $135.64M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2017-12-31 | $66.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $92.07M derived: sum of 2 quarters · filed 2020-03-16 | $111.33M derived: sum of 3 quarters · filed 2020-03-16 | $142.22M 10-K · filed 2020-03-16 | ||
| 2017-09-30 | $25.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $44.69M derived: sum of 2 quarters · filed 2018-11-09 | $75.58M 10-Q · filed 2018-11-09 | $112.50M derived: sum of 4 quarters · filed 2019-03-18 | ||
| 2017-06-30 | $19.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $50.16M 10-Q · filed 2018-08-09 | $87.07M derived: sum of 3 quarters · filed 2019-03-18 | |||
| 2017-03-31 | $30.90M 10-Q · filed 2018-05-10 | $67.81M derived: sum of 2 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | $36.91M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $91.64M 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | $54.73M 10-Q · filed 2017-11-09 | |||||
| 2015-12-31 | $67.04M 10-K · filed 2018-03-19 | |||||
| 2014-03-31 | -$4.86M 10-Q · filed 2014-05-12 | $19.05M derived: sum of 2 quarters · filed 2014-05-12 | $32.78M derived: sum of 3 quarters · filed 2014-05-12 | $46.34M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2013-12-31 | $23.91M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $37.65M derived: sum of 2 quarters · filed 2014-03-17 | $51.20M derived: sum of 3 quarters · filed 2014-03-17 | $66.42M 10-K · filed 2014-03-17 | ||
| 2013-09-30 | $13.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $27.29M derived: sum of 2 quarters · filed 2013-11-13 | $42.51M 10-Q · filed 2013-11-13 | $62.16M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2013-06-30 | $13.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $28.78M 10-Q · filed 2013-08-09 | $48.43M derived: sum of 3 quarters · filed 2014-05-12 | $63.23M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2013-03-31 | $15.22M 10-Q · filed 2014-05-12 | $34.87M derived: sum of 2 quarters · filed 2014-05-12 | $49.67M derived: sum of 3 quarters · filed 2014-05-12 | $75.06M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2012-12-31 | $19.65M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $34.45M derived: sum of 2 quarters · filed 2014-03-17 | $59.84M derived: sum of 3 quarters · filed 2014-03-17 | $75.27M 10-K · filed 2014-03-17 | ||
| 2012-09-30 | $14.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $40.19M derived: sum of 2 quarters · filed 2013-11-13 | $55.62M 10-Q · filed 2013-11-13 | $79.20M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | $25.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $40.82M 10-Q · filed 2013-08-09 | $64.40M derived: sum of 3 quarters · filed 2014-03-17 | $75.59M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | $15.43M 10-Q · filed 2013-05-10 | $39.02M derived: sum of 2 quarters · filed 2014-03-17 | $50.20M derived: sum of 3 quarters · filed 2014-03-17 | $57.87M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2011-12-31 | $23.58M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $34.77M derived: sum of 2 quarters · filed 2014-03-17 | $42.44M derived: sum of 3 quarters · filed 2014-03-17 | $57.64M 10-K · filed 2014-03-17 | ||
| 2011-09-30 | $11.19M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-09 | $18.86M derived: sum of 2 quarters · filed 2012-11-09 | $34.05M 10-Q · filed 2012-11-09 | $2.23M derived: sum of 4 quarters · filed 2013-11-13 | ||
| 2011-06-30 | $7.67M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30 | $22.87M 10-Q/A · filed 2012-08-30 | -$8.95M derived: sum of 3 quarters · filed 2013-11-13 | $18.71M derived: sum of 4 quarters · filed 2013-11-13 | ||
| 2011-03-31 | $15.20M 10-Q · filed 2012-05-10 | -$16.62M derived: sum of 2 quarters · filed 2013-11-13 | $11.04M derived: sum of 3 quarters · filed 2013-11-13 | |||
| 2010-12-31 | -$31.82M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-13 | -$4.16M derived: sum of 2 quarters · filed 2013-11-13 | $18.34M 10-K/A · filed 2013-11-13 | $66.88M 10-K · filed 2012-03-13 | ||
| 2010-09-30 | $27.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $50.15M 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $22.50M 10-Q · filed 2011-08-09 | |||||
| 2009-12-31 | $76.62M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |